• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
RNA-RNA interactions between SARS-CoV-2 and host benefit viral development and evolution during COVID-19 infection.SARS-CoV-2 与宿主之间的 RNA-RNA 相互作用有利于 COVID-19 感染期间病毒的发展和演变。
Brief Bioinform. 2022 Jan 17;23(1). doi: 10.1093/bib/bbab397.
2
SARS-CoV infection crosstalk with human host cell noncoding-RNA machinery: An in-silico approach.SARS-CoV 感染与人类宿主细胞非编码 RNA 机制的串扰:一种计算机模拟方法。
Biomed Pharmacother. 2020 Oct;130:110548. doi: 10.1016/j.biopha.2020.110548. Epub 2020 Jul 28.
3
Viral MicroRNAs Encoded by Nucleocapsid Gene of SARS-CoV-2 Are Detected during Infection, and Targeting Metabolic Pathways in Host Cells.SARS-CoV-2 核衣壳基因编码的病毒 microRNAs 在感染过程中被检测到,并靶向宿主细胞中的代谢途径。
Cells. 2021 Jul 12;10(7):1762. doi: 10.3390/cells10071762.
4
Competing endogenous RNA network mediated by circ_3205 in SARS-CoV-2 infected cells.circ_3205在感染SARS-CoV-2的细胞中介导的竞争性内源性RNA网络
Cell Mol Life Sci. 2022 Jan 17;79(2):75. doi: 10.1007/s00018-021-04119-8.
5
The role of microRNAs in modulating SARS-CoV-2 infection in human cells: a systematic review.microRNAs 在调节人类细胞中 SARS-CoV-2 感染中的作用:系统评价。
Infect Genet Evol. 2021 Jul;91:104832. doi: 10.1016/j.meegid.2021.104832. Epub 2021 Apr 1.
6
IFI44 is an immune evasion biomarker for SARS-CoV-2 and infection in patients with RA.IFI44 是 SARS-CoV-2 的免疫逃逸生物标志物,与 RA 患者的感染相关。
Front Immunol. 2022 Sep 15;13:1013322. doi: 10.3389/fimmu.2022.1013322. eCollection 2022.
7
Decrypting the role of predicted SARS-CoV-2 miRNAs in COVID-19 pathogenesis: A bioinformatics approach.解析预测 SARS-CoV-2 miRNAs 在 COVID-19 发病机制中的作用:一种生物信息学方法。
Comput Biol Med. 2021 Sep;136:104669. doi: 10.1016/j.compbiomed.2021.104669. Epub 2021 Jul 21.
8
What is the potential function of microRNAs as biomarkers and therapeutic targets in COVID-19?microRNAs 在 COVID-19 中作为生物标志物和治疗靶点的潜在功能是什么?
Infect Genet Evol. 2020 Nov;85:104417. doi: 10.1016/j.meegid.2020.104417. Epub 2020 Jun 8.
9
Computational Analysis of Targeting SARS-CoV-2, Viral Entry Proteins ACE2 and TMPRSS2, and Interferon Genes by Host MicroRNAs.宿主 microRNAs 对 SARS-CoV-2、病毒进入蛋白 ACE2 和 TMPRSS2 及干扰素基因的靶向计算分析。
Genes (Basel). 2020 Nov 16;11(11):1354. doi: 10.3390/genes11111354.
10
MicroRNAs in the development of potential therapeutic targets against COVID-19: A narrative review.微小 RNA 在开发针对 COVID-19 的潜在治疗靶点中的作用:叙事性综述。
J Infect Public Health. 2022 Jul;15(7):788-799. doi: 10.1016/j.jiph.2022.06.012. Epub 2022 Jun 21.

引用本文的文献

1
Uncovering active ingredients and mechanisms of Pholiota adiposa in the treatment of Alzheimer's disease based on network pharmacology and bioinformatics.基于网络药理学和生物信息学揭示黄伞治疗阿尔茨海默病的活性成分及作用机制
Sci Rep. 2025 Jul 31;15(1):27981. doi: 10.1038/s41598-025-94861-x.
2
OncoSexome: the landscape of sex-based differences in oncologic diseases.肿瘤性染色体组:肿瘤疾病中基于性别的差异概况。
Nucleic Acids Res. 2025 Jan 6;53(D1):D1443-D1459. doi: 10.1093/nar/gkae1003.
3
SYNBIP 2.0: epitopes mapping, sequence expansion and scaffolds discovery for synthetic binding protein innovation.SYNBIP 2.0:用于合成结合蛋白创新的表位映射、序列扩展和支架发现
Nucleic Acids Res. 2025 Jan 6;53(D1):D595-D603. doi: 10.1093/nar/gkae893.
4
MolBiC: the cell-based landscape illustrating molecular bioactivities.MolBiC:基于细胞的展现分子生物活性的图谱
Nucleic Acids Res. 2025 Jan 6;53(D1):D1683-D1691. doi: 10.1093/nar/gkae868.
5
OrgXenomics: an integrated proteomic knowledge base for patient-derived organoid and xenograft.器官异种组学:一个用于患者来源类器官和异种移植的综合蛋白质组知识库。
Nucleic Acids Res. 2025 Jan 6;53(D1):D504-D515. doi: 10.1093/nar/gkae861.
6
SubCELL: the landscape of subcellular compartment-specific molecular interactions.亚细胞:亚细胞区室特异性分子相互作用的全景图。
Nucleic Acids Res. 2025 Jan 6;53(D1):D738-D747. doi: 10.1093/nar/gkae863.
7
FERREG: ferroptosis-based regulation of disease occurrence, progression and therapeutic response.基于铁死亡的疾病发生、进展和治疗反应的调控。
Brief Bioinform. 2024 Mar 27;25(3). doi: 10.1093/bib/bbae223.
8
A task-specific encoding algorithm for RNAs and RNA-associated interactions based on convolutional autoencoder.基于卷积自动编码器的 RNA 及其相关相互作用的特定任务编码算法。
Nucleic Acids Res. 2023 Nov 27;51(21):e110. doi: 10.1093/nar/gkad929.
9
TheMarker: a comprehensive database of therapeutic biomarkers.TheMarker:一个全面的治疗性生物标志物数据库。
Nucleic Acids Res. 2024 Jan 5;52(D1):D1450-D1464. doi: 10.1093/nar/gkad862.
10
VARIDT 3.0: the phenotypic and regulatory variability of drug transporter.VARIDT 3.0:药物转运体的表型和调控变异性。
Nucleic Acids Res. 2024 Jan 5;52(D1):D1490-D1502. doi: 10.1093/nar/gkad818.

本文引用的文献

1
Plasma metabolomic and lipidomic alterations associated with COVID-19.与新型冠状病毒肺炎相关的血浆代谢组学和脂质组学改变。
Natl Sci Rev. 2020 Jul;7(7):1157-1168. doi: 10.1093/nsr/nwaa086. Epub 2020 Apr 28.
2
On the origin and continuing evolution of SARS-CoV-2.关于严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的起源及持续进化
Natl Sci Rev. 2020 Jun;7(6):1012-1023. doi: 10.1093/nsr/nwaa036. Epub 2020 Mar 3.
3
PD-L1 Dysregulation in COVID-19 Patients.COVID-19患者中的PD-L1失调
Front Immunol. 2021 Jun 7;12:695242. doi: 10.3389/fimmu.2021.695242. eCollection 2021.
4
miRTargetLink 2.0-interactive miRNA target gene and target pathway networks.miRTargetLink 2.0-interactive miRNA 靶基因和靶途径网络。
Nucleic Acids Res. 2021 Jul 2;49(W1):W409-W416. doi: 10.1093/nar/gkab297.
5
One year of SARS-CoV-2 evolution.SARS-CoV-2 一年的进化。
Cell Host Microbe. 2021 Apr 14;29(4):503-507. doi: 10.1016/j.chom.2021.02.017. Epub 2021 Feb 24.
6
The miRNA: a small but powerful RNA for COVID-19.miRNA:COVID-19 中的一种小而强大的 RNA。
Brief Bioinform. 2021 Mar 22;22(2):1137-1149. doi: 10.1093/bib/bbab062.
7
Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia.托珠单抗治疗新冠肺炎合并肺炎住院患者的疗效。
N Engl J Med. 2021 Jan 7;384(1):20-30. doi: 10.1056/NEJMoa2030340. Epub 2020 Dec 17.
8
A Mini-Review on Cell Cycle Regulation of Coronavirus Infection.冠状病毒感染的细胞周期调控综述
Front Vet Sci. 2020 Nov 5;7:586826. doi: 10.3389/fvets.2020.586826. eCollection 2020.
9
The noncoding and coding transcriptional landscape of the peripheral immune response in patients with COVID-19.新型冠状病毒肺炎患者外周免疫反应的非编码和编码转录图谱
Clin Transl Med. 2020 Oct;10(6):e200. doi: 10.1002/ctm2.200.
10
Efficacy of Tocilizumab in Patients Hospitalized with Covid-19.托珠单抗治疗 COVID-19 住院患者的疗效。
N Engl J Med. 2020 Dec 10;383(24):2333-2344. doi: 10.1056/NEJMoa2028836. Epub 2020 Oct 21.

SARS-CoV-2 与宿主之间的 RNA-RNA 相互作用有利于 COVID-19 感染期间病毒的发展和演变。

RNA-RNA interactions between SARS-CoV-2 and host benefit viral development and evolution during COVID-19 infection.

机构信息

College of Pharmaceutical Sciences in Zhejiang University, and the First Affiliated Hospital of Zhejiang University School of Medicine, China.

College of Pharmaceutical Sciences in Zhejiang University, China.

出版信息

Brief Bioinform. 2022 Jan 17;23(1). doi: 10.1093/bib/bbab397.

DOI:10.1093/bib/bbab397
PMID:34585235
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8500159/
Abstract

Some studies reported that genomic RNA of SARS-CoV-2 can absorb a few host miRNAs that regulate immune-related genes and then deprive their function. In this perspective, we conjecture that the absorption of the SARS-CoV-2 genome to host miRNAs is not a coincidence, which may be an indispensable approach leading to viral survival and development in host. In our study, we collected five datasets of miRNAs that were predicted to interact with the genome of SARS-CoV-2. The targets of these miRNAs in the five groups were consistently enriched immune-related pathways and virus-infectious diseases. Interestingly, the five datasets shared no one miRNA but their targets shared 168 genes. The signaling pathway enrichment of 168 shared targets implied an unbalanced immune response that the most of interleukin signaling pathways and none of the interferon signaling pathways were significantly different. Protein-protein interaction (PPI) network using the shared targets showed that PPI pairs, including IL6-IL6R, were related to the process of SARS-CoV-2 infection and pathogenesis. In addition, we found that SARS-CoV-2 absorption to host miRNA could benefit two popular mutant strains for more infectivity and pathogenicity. Conclusively, our results suggest that genomic RNA absorption to host miRNAs may be a vital approach by which SARS-CoV-2 disturbs the host immune system and infects host cells.

摘要

一些研究报道称,SARS-CoV-2 的基因组 RNA 可以吸收一些宿主 miRNA,从而调节免疫相关基因的功能。从这个角度来看,我们推测 SARS-CoV-2 基因组对宿主 miRNA 的吸收并非偶然,这可能是病毒在宿主中生存和发展的必要途径。在我们的研究中,我们收集了五组预测与 SARS-CoV-2 基因组相互作用的 miRNA 数据集。这五组 miRNA 的靶基因一致富集于免疫相关通路和病毒感染性疾病。有趣的是,这五组数据集没有一个共同的 miRNA,但它们的靶基因共享了 168 个基因。这 168 个共享靶基因的信号通路富集表明,免疫反应失衡,大多数白细胞介素信号通路和干扰素信号通路没有显著差异。使用共享靶基因构建的蛋白质-蛋白质相互作用(PPI)网络显示,包括 IL6-IL6R 在内的 PPI 对与 SARS-CoV-2 感染和发病机制过程有关。此外,我们发现 SARS-CoV-2 对宿主 miRNA 的吸收可能有利于两种流行的突变株,使其具有更高的传染性和致病性。综上所述,我们的研究结果表明,基因组 RNA 对宿主 miRNA 的吸收可能是 SARS-CoV-2 扰乱宿主免疫系统并感染宿主细胞的重要途径。